English

ROBERTS PHARMACEUTICAL CORP

EDGAR

Quarterly report amendment (10-Q/A) · filed 1999-11-22

24 filing records in this dataset, filed from 1995-05-12 to 1999-11-22. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

51.8 million USD

1999-09-30 · USD

Exact inputs and evidence

Revenue: 51766000 USD Source

Operating margin

25.21%

1999-09-30 · %

Exact inputs and evidence

Operating Income: 13048000 USD Source
Revenue: 51766000 USD Source

Operating cash flow

16 million USD

1999-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 28788000 USD Source
Operating Cash Flow: 12829000 USD Source

Cash and cash equivalents: 31.4 million USD 1999-09-30 Source
Exact value

31426000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

201 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Revenue: 173764000 USD · 1998-01-01 – 1998-12-31 Source
Revenue: 118720000 USD · 1998-01-01 – 1998-09-30 Source
Revenue: 44083000 USD · 1999-01-01 – 1999-03-31 Source
Revenue: 49936000 USD · 1999-04-01 – 1999-06-30 Source
Revenue: 51766000 USD · 1999-07-01 – 1999-09-30 Source

Net income

26.3 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Net income: 16787000 USD · 1998-01-01 – 1998-12-31 Source
Net income: 10208000 USD · 1998-01-01 – 1998-09-30 Source
Net income: 5015000 USD · 1999-01-01 – 1999-03-31 Source
Net income: 7487000 USD · 1999-04-01 – 1999-06-30 Source
Net income: 7252000 USD · 1999-07-01 – 1999-09-30 Source

Operating cash flow

46.5 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: 32426000 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: 14722000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: 7155000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: 12829000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: 7155000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: 28788000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: 12829000 USD · 1999-01-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-11-22.

Financial data available through: 1998-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1998-12-31
Operating income: 6 of 11 periods available· newest 1998-12-31
Net income: 6 of 11 periods available· newest 1998-12-31
Operating cash flow: 6 of 11 periods available· newest 1998-12-31
capital expenditure: No compatible figures in this window
Total assets: 6 of 11 periods available· newest 1998-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 1998-12-31
Current liabilities: 6 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+42.9%

Prior period

USD 121.61 million

1997-01-01 – 1997-12-31
Current period

USD 173.76 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

173764000 − 121612000 = 52152000 USD

121612000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
173764000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ROBERTS PHARMACEUTICAL CORP · 1998-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Year-over-year change in Revenue: 52152000 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 173764000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1017 Input fundies:Revenue: 121612000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1017
The citation records this snapshot. The page link may show a newer release later.
Net income
+566.9%

Prior period

USD 2.52 million

1997-01-01 – 1997-12-31
Current period

USD 16.79 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

16787000 − 2517000 = 14270000 USD

2517000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
16787000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ROBERTS PHARMACEUTICAL CORP · 1998-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Year-over-year change in Net income: 14270000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 16787000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1128 Input fundies:NetIncome: 2517000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1128
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+812.9%

Prior period

USD 3.55 million

1997-01-01 – 1997-12-31
Current period

USD 32.43 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

32426000 − 3552000 = 28874000 USD

3552000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
32426000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ROBERTS PHARMACEUTICAL CORP · 1998-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Year-over-year change in Operating cash flow: 28874000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 32426000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1151 Input fundies:OperatingCashFlow: 3552000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1151
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 173.76 million 100% of revenue
Operating costs Derived USD 146.39 million 84% of revenue
Operating income USD 27.38 million 16% of revenue
Tax, interest and other Derived USD 10.59 million 6.1% of revenue
Net income USD 16.79 million 9.7% of revenue

Cash

Operating cash flow USD 32.43 million 19% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 13%86%
1994 22%70%
1995 Net loss: net income was −21% of revenue.
1996 Operating loss: operating costs were 151% of revenue.
1997 Operating loss: operating costs were 101% of revenue.
1998 9.7%84%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	55612000	47762000 Derived	7850000	622000 Derived	7228000	Unavailable	Source 1993-01-01 – 1993-12-31: 55612000 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: 7850000 USD Inspect Operating Income Open source 1993-01-01 – 1993-12-31: 7228000 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: 1645000 USD Inspect Operating Cash Flow Open source
1994 1994-01-01 – 1994-12-31	87437000	61635000 Derived	25802000	6390000 Derived	19412000	Unavailable	Source 1994-01-01 – 1994-12-31: 87437000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: 25802000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: 19412000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -653000 USD Inspect Operating Cash Flow Open source
1995 1995-01-01 – 1995-12-31	113380000	106507000 Derived	6873000	31215000 Derived	-24342000	Unavailable	Source 1995-01-01 – 1995-12-31: 113380000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 6873000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -24342000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 22762000 USD Inspect Operating Cash Flow Open source
1996 1996-01-01 – 1996-12-31	98075000	148270000 Derived	-50195000	-16476000 Derived	-33719000	Unavailable	Source 1996-01-01 – 1996-12-31: 98075000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -50195000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -33719000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -3222000 USD Inspect Operating Cash Flow Open source
1997 1997-01-01 – 1997-12-31	121612000	122374000 Derived	-762000	-3279000 Derived	2517000	Unavailable	Source 1997-01-01 – 1997-12-31: 121612000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -762000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: 2517000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 3552000 USD Inspect Operating Cash Flow Open source
1998 1998-01-01 – 1998-12-31	173764000	146386000 Derived	27378000	10591000 Derived	16787000	Unavailable	Source 1998-01-01 – 1998-12-31: 173764000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 27378000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 16787000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 32426000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 173.8M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	55612000	Revenue: 55612000 Open source
19941994-12-31	Revenue	87437000	Revenue: 87437000 Open source
19951995-12-31	Revenue	113380000	Revenue: 113380000 Open source
19961996-12-31	Revenue	98075000	Revenue: 98075000 Open source
19971997-12-31	Revenue	121612000	Revenue: 121612000 Open source
19981998-12-31	Revenue	173764000	Revenue: 173764000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

42.9% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 55612000 Open source
19941994-12-31	Year over year	57.2%	Revenue: 87437000 Open source Revenue: 55612000 Open source
19951995-12-31	Year over year	29.7%	Revenue: 113380000 Open source Revenue: 87437000 Open source
19961996-12-31	Year over year	-13.5%	Revenue: 98075000 Open source Revenue: 113380000 Open source
19971997-12-31	Year over year	24%	Revenue: 121612000 Open source Revenue: 98075000 Open source
19981998-12-31	Year over year	42.9%	Revenue: 173764000 Open source Revenue: 121612000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 15.8% 1998

Net margin 9.7% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Operating margin	14.1%	Operating Income: 7850000 Open source Revenue: 55612000 Open source
19941994-12-31	Operating margin	29.5%	Operating Income: 25802000 Open source Revenue: 87437000 Open source
19951995-12-31	Operating margin	6.1%	Operating Income: 6873000 Open source Revenue: 113380000 Open source
19961996-12-31	Operating margin	-51.2%	Operating Income: -50195000 Open source Revenue: 98075000 Open source
19971997-12-31	Operating margin	-0.6%	Operating Income: -762000 Open source Revenue: 121612000 Open source
19981998-12-31	Operating margin	15.8%	Operating Income: 27378000 Open source Revenue: 173764000 Open source
19931993-12-31	Net margin	13%	Net Income: 7228000 Open source Revenue: 55612000 Open source
19941994-12-31	Net margin	22.2%	Net Income: 19412000 Open source Revenue: 87437000 Open source
19951995-12-31	Net margin	-21.5%	Net Income: -24342000 Open source Revenue: 113380000 Open source
19961996-12-31	Net margin	-34.4%	Net Income: -33719000 Open source Revenue: 98075000 Open source
19971997-12-31	Net margin	2.1%	Net Income: 2517000 Open source Revenue: 121612000 Open source
19981998-12-31	Net margin	9.7%	Net Income: 16787000 Open source Revenue: 173764000 Open source
19931993-12-31	Free cash flow margin	Not reported	Revenue: 55612000 Open source Operating Cash Flow: 1645000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 87437000 Open source Operating Cash Flow: -653000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 113380000 Open source Operating Cash Flow: 22762000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 98075000 Open source Operating Cash Flow: -3222000 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 121612000 Open source Operating Cash Flow: 3552000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 173764000 Open source Operating Cash Flow: 32426000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 32.4M 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	1645000	Operating Cash Flow: 1645000 Open source
19941994-12-31	Operating cash flow	-653000	Operating Cash Flow: -653000 Open source
19951995-12-31	Operating cash flow	22762000	Operating Cash Flow: 22762000 Open source
19961996-12-31	Operating cash flow	-3222000	Operating Cash Flow: -3222000 Open source
19971997-12-31	Operating cash flow	3552000	Operating Cash Flow: 3552000 Open source
19981998-12-31	Operating cash flow	32426000	Operating Cash Flow: 32426000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	Unavailable	Operating Cash Flow: 1645000 Open source
19941994-12-31	Free cash flow	Unavailable	Operating Cash Flow: -653000 Open source
19951995-12-31	Free cash flow	Unavailable	Operating Cash Flow: 22762000 Open source
19961996-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3222000 Open source
19971997-12-31	Free cash flow	Unavailable	Operating Cash Flow: 3552000 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: 32426000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	Total Assets: 343103000 Open source
1994-12-31	Liabilities / assets	Not reported	Total Assets: 336192000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 340290000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 372225000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 367855000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 526236000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.73× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Current assets / current liabilities	2.22×	Current Assets: 127846000 Open source Current Liabilities: 57659000 Open source
19941994-12-31	Current assets / current liabilities	1.78×	Current Assets: 96201000 Open source Current Liabilities: 53934000 Open source
19951995-12-31	Current assets / current liabilities	1.15×	Current Assets: 93770000 Open source Current Liabilities: 81782000 Open source
19961996-12-31	Current assets / current liabilities	3.05×	Current Assets: 156927000 Open source Current Liabilities: 51482000 Open source
19971997-12-31	Current assets / current liabilities	3.45×	Current Assets: 137987000 Open source Current Liabilities: 39981000 Open source
19981998-12-31	Current assets / current liabilities	2.73×	Current Assets: 157234000 Open source Current Liabilities: 57687000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	USD 7.23 million Exact value Exact value: 7228000 USD 1993-01-01 – 1993-12-31: 7228000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1993-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: 7228000 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7228000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-96-001047.txt#2039 The citation records this snapshot. The page link may show a newer release later.	USD 1.65 million Exact value Exact value: 1645000 USD 1993-01-01 – 1993-12-31: 1645000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1993-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: 1645000 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1645000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-96-001047.txt#2058 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1994 1994-01-01 – 1994-12-31	USD 19.41 million Exact value Exact value: 19412000 USD 1994-01-01 – 1994-12-31: 19412000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1994-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: 19412000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 19412000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-97-001485.txt#2327 The citation records this snapshot. The page link may show a newer release later.	−USD 653,000 Exact value Exact value: -653000 USD 1994-01-01 – 1994-12-31: -653000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1994-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: -653000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -653000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-97-001485.txt#2350 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 24.34 million Exact value Exact value: -24342000 USD 1995-01-01 – 1995-12-31: -24342000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1995-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: -24342000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24342000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-98-001619.txt#2160 The citation records this snapshot. The page link may show a newer release later.	USD 22.76 million Exact value Exact value: 22762000 USD 1995-01-01 – 1995-12-31: 22762000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1995-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: 22762000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22762000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-98-001619.txt#2182 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 33.72 million Exact value Exact value: -33719000 USD 1996-01-01 – 1996-12-31: -33719000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1996-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: -33719000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33719000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1128 The citation records this snapshot. The page link may show a newer release later.	−USD 3.22 million Exact value Exact value: -3222000 USD 1996-01-01 – 1996-12-31: -3222000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1996-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: -3222000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3222000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1151 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	USD 2.52 million Exact value Exact value: 2517000 USD 1997-01-01 – 1997-12-31: 2517000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1997-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: 2517000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2517000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1128 The citation records this snapshot. The page link may show a newer release later.	USD 3.55 million Exact value Exact value: 3552000 USD 1997-01-01 – 1997-12-31: 3552000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1997-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: 3552000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3552000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1151 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	USD 16.79 million Exact value Exact value: 16787000 USD 1998-01-01 – 1998-12-31: 16787000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ROBERTS PHARMACEUTICAL CORP · 1998-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Net Income: 16787000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 16787000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1128 The citation records this snapshot. The page link may show a newer release later.	USD 32.43 million Exact value Exact value: 32426000 USD 1998-01-01 – 1998-12-31: 32426000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ROBERTS PHARMACEUTICAL CORP · 1998-12-31 ROBERTS PHARMACEUTICAL CORP (edgar:853022) Operating Cash Flow: 32426000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:20Z Snapshot: 15f7cd78a9df686de2088ba5a59c05babc993a9028ca2a2afcf131af985de09e Dimensions: Consolidated View: https://fundies.io/companies/edgar/853022/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 32426000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/853022/0000950130-99-006680.txt#1151 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000853022, 853022, edgar:853022

ROBERTS PHARMACEUTICAL CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation